Literature DB >> 22941543

Survivor bias and risk assessment.

Dave P Miller, Mardi Gomberg-Maitland, Marc Humbert.   

Abstract

Mesh：

Year:  2012        PMID： 22941543     DOI： 10.1183/09031936.00094112

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

1.  Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.

Authors:  Mei-Sing Ong; Mary P Mullen; Eric D Austin; Peter Szolovits; Marc D Natter; Alon Geva; Tianxi Cai; Sek Won Kong; Kenneth D Mandl
Journal:  Circ Res       Date:  2017-06-13       Impact factor: 17.367

2.  Assessing risk in pulmonary arterial hypertension: what we know, what we don't.

Authors:  Raymond L Benza; Harrison W Farber; Mona Selej; Mardi Gomberg-Maitland
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

3.  Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.

Authors:  Robert P Frantz; Harrison W Farber; David B Badesch; C Greg Elliott; Adaani E Frost; Michael D McGoon; Carol Zhao; David R Mink; Mona Selej; Raymond L Benza
Journal:  Chest       Date:  2018-01-31       Impact factor: 9.410

4.  The prevalence and clinical presentation of Hirschsprung's disease in preterm infants: a systematic review and meta-analysis.

Authors:  Yi Chen; Xiaojian Yuan; Yonglin Li; Shannan Wu; Xuefeng Miao; Junfei Gong; Yuntao Huang
Journal:  Pediatr Surg Int       Date:  2022-02-10       Impact factor: 1.827

5.  Outcomes of ICU Patients With a Discharge Diagnosis of Critical Illness Polyneuromyopathy: A Propensity-Matched Analysis.

Authors:  Daniel A Kelmenson; Natalie Held; Richard R Allen; Dianna Quan; Ellen L Burnham; Brendan J Clark; P Michael Ho; Tyree H Kiser; R William Vandivier; Marc Moss
Journal:  Crit Care Med       Date:  2017-12       Impact factor: 7.598

6.  Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.

Authors:  Kevin Y Chang; Sue Duval; David B Badesch; Todd M Bull; Murali M Chakinala; Teresa De Marco; Robert P Frantz; Anna Hemnes; Stephen C Mathai; Erika Berman Rosenzweig; John J Ryan; Thenappan Thenappan
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

7.  Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).

Authors:  Ioana R Preston; Kari E Roberts; Dave P Miller; Ginny P Sen; Mona Selej; Wade W Benton; Nicholas S Hill; Harrison W Farber
Journal:  Circulation       Date:  2015-10-28       Impact factor: 29.690

8.  Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.

Authors:  Robert P Frantz; Robert J Schilz; Murali M Chakinala; David B Badesch; Adaani E Frost; Vallerie V McLaughlin; Robyn J Barst; Daniel M Rosenberg; Dave P Miller; Brian K Hartline; Wade W Benton; Harrison W Farber
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

9.  Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN.

Authors:  Gérald Simonneau; Richard N Channick; Marion Delcroix; Nazzareno Galiè; Hossein-Ardeschir Ghofrani; Pavel Jansa; Franck-Olivier Le Brun; Sanjay Mehta; Loic Perchenet; Tomás Pulido; B K S Sastry; Olivier Sitbon; Rogério Souza; Adam Torbicki; Lewis J Rubin
Journal:  Eur Respir J       Date:  2015-10-22       Impact factor: 16.671

10.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.

Authors:  Jonathan D W Evans; Barbara Girerd; David Montani; Xiao-Jian Wang; Nazzareno Galiè; Eric D Austin; Greg Elliott; Koichiro Asano; Ekkehard Grünig; Yi Yan; Zhi-Cheng Jing; Alessandra Manes; Massimiliano Palazzini; Lisa A Wheeler; Ikue Nakayama; Toru Satoh; Christina Eichstaedt; Katrin Hinderhofer; Matthias Wolf; Erika B Rosenzweig; Wendy K Chung; Florent Soubrier; Gérald Simonneau; Olivier Sitbon; Stefan Gräf; Stephen Kaptoge; Emanuele Di Angelantonio; Marc Humbert; Nicholas W Morrell
Journal:  Lancet Respir Med       Date:  2016-01-19       Impact factor: 30.700
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.